Skip to main content
. 2016 Feb 29;22(5-6):469–479. doi: 10.1089/ten.tea.2015.0355

Table 1.

Treatment Groups Evaluated in the Canine Mandibular Ridge Saddle Defects

Treatment group Particle Particle diameter (μm) rhBMP-2 μg·cm−3defect volume n
LV/BG-L Bioactive glass 150–212 100 6
LV/BG-H Bioactive glass 150–212 400 6
LV/CM-L MASTERGRAFT 100–500 100 6
LV/CM-H MASTERGRAFT 100–500 400 6

rhBMP-2, recombinant human bone morphogenetic protein-2.